Risultati della ricerca - Bryan Oronsky

Raffina i risultati
  1. 1
    Profile EpicentRx, Inc

    Profile EpicentRx, Inc di Bryan Oronsky

    Pubblicazione 2023-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  2. 2
    What Exactly Is Inflammation (and What Is It Not?)

    What Exactly Is Inflammation (and What Is It Not?) di Bryan Oronsky, Scott Caroen, Tony Reid

    Pubblicazione 2022-11-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Commentary on oncolytic viruses: past, present, and future

    Commentary on oncolytic viruses: past, present, and future di Christopher Larson, Bryan Oronsky, Tony R Reid

    Pubblicazione 2023-12-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  4. 4
    RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature

    RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature di Vinay P. Jani, Robert Asaro, Bryan Oronsky, Pedro Cabrales

    Pubblicazione 2021-04-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply

    Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply di Bryan Oronsky, Christopher Larson, Scott Caroen, Tony R. Reid

    Pubblicazione 2022-12-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

    Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas di Bryan Oronsky, Patrick C. Ma, Daniel Morgensztern, Corey A. Carter

    Pubblicazione 2017-12-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  7. 7
    A short discussion about the SARS-CoV-2 mRNA-1273 vaccine

    A short discussion about the SARS-CoV-2 mRNA-1273 vaccine di Bryan Oronsky, Harry E. Gruber, Wendy Reiners, Tony R. Reid

    Pubblicazione 2021-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  8. 8
    What's New in SCLC? A Review

    What's New in SCLC? A Review di Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Corey A. Carter

    Pubblicazione 2017-10-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock

    Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock di Chad Brouse, Daniel Ortiz, Yan Su, Bryan Oronsky, Jan Scicinski, Pedro Cabrales

    Pubblicazione 2015-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  10. 10
    A Review of Newly Diagnosed Glioblastoma

    A Review of Newly Diagnosed Glioblastoma di Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Navjot Sandhu, Susan J. Knox

    Pubblicazione 2021-02-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  11. 11
    A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma

    A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma di Howard Fine, Tony Reid, Scott Caroen, Bryan Oronsky, Nacer Abrouk, Nicholas Butowski

    Pubblicazione 2023-06-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  12. 12
    RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist

    RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist di Bryan Oronsky, Lori Takahashi, Richard Gordon, Pedro Cabrales, Scott Caroen, Tony Reid

    Pubblicazione 2023-05-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Rewriting the Epigenetic Code for Tumor Resensitization: A Review

    Rewriting the Epigenetic Code for Tumor Resensitization: A Review di Bryan Oronsky, Neil Oronsky, Jan Scicinski, Gary Fanger, Michelle Lybeck, Tony Reid

    Pubblicazione 2014-10-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Hypothesis: AdAPT-001 and pseudoprogression – when seeing is not necessarily believing

    Hypothesis: AdAPT-001 and pseudoprogression – when seeing is not necessarily believing di Anthony Conley, Christopher Larson, Bryan Oronsky, Meaghan Stirn, Tony R Reid, Scott Caroen

    Pubblicazione 2024-06-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  15. 15
    A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

    A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet di Hope Cottrill MD, Stephanie Cason, Scott Caroen, Bryan Oronsky MD, Elvis Donaldson MD

    Pubblicazione 2018-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report

    Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report di Christina Brzezniak, Bryan Oronsky, Corey A. Carter, Bennett Thilagar, Scott Caroen, Karen Zeman

    Pubblicazione 2017-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Nucleocapsid as a next-generation COVID-19 vaccine candidate

    Nucleocapsid as a next-generation COVID-19 vaccine candidate di Bryan Oronsky, Christopher Larson, Scott Caroen, Farah Hedjran, Ana Sanchez, Elena Prokopenko, Tony Reid

    Pubblicazione 2022-09-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME)

    Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME) di Tony Reid, Bryan Oronsky, Scott Caroen, Mary Quinn, Jeannie Williams, Pedro Cabrales, Nacer Abrouk

    Pubblicazione 2023-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  19. 19
    RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"

    RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic" di Bryan Oronsky, Corey A. Carter, Scott Caroen, Curtis Scribner, Arnold Oronsky, Tony R. Reid

    Pubblicazione 2020-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient

    Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient di Santosh Kesari, Jeannie Williams, Erica Burbano, Meaghan Stirn, Scott Caroen, Bryan Oronsky, Tony Reid, Chris Larson

    Pubblicazione 2023-03-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: